FNFDCM
GSK icon

Folger Nolan Fleming Douglas Capital Management’s GSK GSK Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-600
Closed -$34K – 174
2014
Q3 		$34K Buy
+600
New +$36.8K 0.01% 169

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's GSK Position: Q4 2014 in Review

Folger Nolan Fleming Douglas Capital Management sold out of GSK (GSK) in Q4 2014, closing a stake of 600 shares — an estimated $34K sold.

Folger Nolan Fleming Douglas Capital Management first reported a position in GSK in Q3 2014 and held it in 1 quarter. The position peaked at $34K in Q3 2014. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Folger Nolan Fleming Douglas Capital Management reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • Folger Nolan Fleming Douglas Capital Management sold 600 GSK shares in Q4 2014, an estimated $34K.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in GSK in Q3 2014 and held it in 1 quarter.
  • Folger Nolan Fleming Douglas Capital Management's GSK position peaked at $34K in Q3 2014.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q4 2014, filed 10 Feb 2015.